N07AA01 - Neostigmine |
Probably Not Porphyrinogenic |
PNP |
Rationale
No data pointing to CYP-interaction. References consider it safe.
Chemical description
Cholinesterase inhibitor of short duration used in intestinal and bladder atonia. Hydrolyzed by cholinesterases. No data pointing to CYP-metabolism.
Ipnet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Explore alternative drugs in similar therapeutic classes
References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | Australian List
Australian Porphyria Association No longer maintained
|
|
| 2. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 3. | South African List
Porphyria South Africa No longer maintained
|
|
Tradenames
Neostigminemethylsulfaat · Prostigmin 
Prostigmine 
Neostigmina 
Neostigmine · Stigmosan 
Miostin · Neostigmina 
Prostigmin 
Neostigmine · Prostigmin 
Neostigmin 
Neostig 
Polstigminum 
Neostigmina · Neostigmina Metilsulfato · Prostigmine · Stimiven 
Neostigmine Methylsulfate · Neostigmine Methylsulphate · Prostigmin 
Setisin 
Neostigmine Methylsulfate · Neostigmine Omega 
Neostigmin · Neostigmina · Syntostigmin 
Neostigmine 
Neostigmine 
Neostigmin 
Intrastigmina · Neostig · Neostigmin · Neostigmina · Prostigmin · Syntostigmin 
Syntostigmin